Detalles de la búsqueda
1.
Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysis.
Mol Psychiatry
; 28(6): 2320-2327, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37173452
2.
Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort.
BMC Psychiatry
; 22(1): 342, 2022 05 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35581641
3.
Influence of polygenic risk scores on lipid levels and dyslipidemia in a psychiatric population receiving weight gain-inducing psychotropic drugs.
Pharmacogenet Genomics
; 27(12): 464-472, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28945215
4.
Publisher Correction: Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort.
BMC Psychiatry
; 22(1): 457, 2022 Jul 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35804331
5.
Association of genetic risk scores with body mass index in Swiss psychiatric cohorts.
Pharmacogenet Genomics
; 26(5): 208-17, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26918956
6.
Prediction of early weight gain during psychotropic treatment using a combinatorial model with clinical and genetic markers.
Pharmacogenet Genomics
; 26(12): 547-557, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27741037
7.
Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments.
Pharmacogenet Genomics
; 25(5): 246-58, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25751397
8.
Association of PCK1 with Body Mass Index and Other Metabolic Features in Patients With Psychotropic Treatments.
J Clin Psychopharmacol
; 35(5): 544-52, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26280835
9.
AI algorithm combined with RNA editing-based blood biomarkers to discriminate bipolar from major depressive disorders in an external validation multicentric cohort.
J Affect Disord
; 356: 385-393, 2024 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38615844
10.
DNA methylation may partly explain psychotropic drug-induced metabolic side effects: results from a prospective 1-month observational study.
Clin Epigenetics
; 16(1): 36, 2024 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38419113
11.
The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samples.
Lancet Reg Health Eur
; 22: 100493, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36039146
12.
Valproate is associated with early decrease of high-density lipoprotein cholesterol levels in the psychiatric population.
Basic Clin Pharmacol Toxicol
; 129(1): 26-35, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33733594
13.
Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort.
Transl Psychiatry
; 11(1): 360, 2021 06 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34226496
14.
Associations Between High Plasma Methylxanthine Levels, Sleep Disorders and Polygenic Risk Scores of Caffeine Consumption or Sleep Duration in a Swiss Psychiatric Cohort.
Front Psychiatry
; 12: 756403, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34987426
15.
Evaluation of Cardiometabolic Risk in a Large Psychiatric Cohort and Comparison With a Population-Based Sample in Switzerland.
J Clin Psychiatry
; 81(3)2020 03 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32237298
16.
Amisulpride: Real-World Evidence of Dose Adaptation and Effect on Prolactin Concentrations and Body Weight Gain by Pharmacokinetic/Pharmacodynamic Analyses.
Clin Pharmacokinet
; 59(3): 371-382, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31552612
17.
Psychological trauma occurring during adolescence is associated with an increased risk of greater waist circumference in Early Psychosis patients treated with psychotropic medication.
PLoS One
; 15(12): e0242569, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33270646
18.
Psychotropic drug-induced genetic-epigenetic modulation of CRTC1 gene is associated with early weight gain in a prospective study of psychiatric patients.
Clin Epigenetics
; 11(1): 198, 2019 12 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31878957
19.
Lipid Disturbances in Adolescents Treated With Second-Generation Antipsychotics: Clinical Determinants of Plasma Lipid Worsening and New-Onset Hypercholesterolemia.
J Clin Psychiatry
; 80(3)2019 04 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30997960
20.
Association Between Plasma Caffeine and Other Methylxanthines and Metabolic Parameters in a Psychiatric Population Treated With Psychotropic Drugs Inducing Metabolic Disturbances.
Front Psychiatry
; 9: 573, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30473668